Results 61 to 70 of about 2,044 (190)
ESC Heart Failure, Volume 12, Issue 4, Page 2631-2642, August 2025.Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta +10 more
wiley +1 more source
Urban air pollution and health inequities: a workshop report. [PDF]
, 2001 Over the past three decades, an array of legislation with attendant regulations has been implemented to enhance the quality of the environment and thereby improve the public's health.
American Lung Association
core +1 more source
Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study. [PDF]
, 2016 INTRODUCTION: Over 80% of the nearly 1 million men diagnosed with prostate cancer annually worldwide present with localised or locally advanced non-metastatic disease.
Gavin, Anna +5 more
core +3 more sources
As-Cast Residual Stresses in an Aluminum Alloy AA6063 Billet: Neutron Diffraction Measurements and Finite Element Modeling [PDF]
, 2018 The presence of thermally induced residual stresses, created during the industrial direct chill (DC) casting process of aluminum alloys, can cause both significant safety concerns and the formation of defects during downstream processing.
Drezet, J.-M, Phillion, A.
core
European Journal of Heart Failure, Volume 27, Issue 3, Page 566-576, March 2025.Abstract Aims Patients with a reduced left ventricular ejection fraction (LVEF) following an acute myocardial infarction (MI) are considered to be at risk of progressive adverse cardiac remodelling which can lead to the development of heart failure and death. The early addition of a sodium–glucose cotransporter 2 (SGLT2) inhibitor to standard treatment
Jaclyn Carberry +24 more
wiley +1 more source
Brief Overview of the Late-Breaking Trials Presented at ACC’24: Part 1
Indian Journal of Clinical CardiologyIn this journal scan, we provide a brief overview of the late-breaking trials presented at the American College of Cardiology (ACC) Conference held in Atlanta, Georgia, from April 6 to 8, 2024, and their relevance to our daily clinical practice.
Praveen Nagula +1 more
doaj +1 more source
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study. [PDF]
, 2018 Purpose: To validate a new 5-tier prognostic classification system to better discriminate cancer specific mortality in men diagnosed with primary non-metastatic prostate cancer.
Bratt, O., +7 more
core +3 more sources
Public Health Challenges, Volume 4, Issue 1, March 2025.ABSTRACT The Mediterranean Sea is the risky path utilized by migrants primarily seeking economic and physical security in Europe. Drowning is the most lethal among the many hardships they face on their way. In the pursuit of protecting individuals between countries of origin and destination, many European Union (EU) member states worked to decrease the
Christopher Maatouk +11 more
wiley +1 more source
The challenges of cybercrime governance in the European Union [PDF]
, 2018 Information and Communications Technologies, in particular the Internet, have been an increasingly important aspect of global social, political and economic life for two decades, and are the backbone of the global information society today.
Christou, George
core +1 more source
ESC Heart Failure, Volume 12, Issue 1, Page 8-42, February 2025.Abstract In the last years, major progress has occurred in heart failure (HF) management. The 2023 ESC focused update of the 2021 HF guidelines introduced new key recommendations based on the results of the last years of science. First, two drugs, sodium–glucose co‐transporter‐2 (SGLT2) inhibitors and finerenone, a novel nonsteroidal, selective ...
Alberto Beghini +12 more
wiley +1 more source